-
1 month ago | 
alsnewstoday.com | Mary Chapman |Lindsey Shapiro |Andrea Lobo |Teresa Carvalho
The Muscular Dystrophy Association (MDA) is once again hosting its annual gathering, the MDA Clinical & Scientific Conference. The 2025 event will take place on March 16-19 in Dallas at the Hilton Anatole. The four-day event will bring together scientists, clinicians, affiliated healthcare providers, academicians, advocates, and industry leaders from around the world to explore the latest advances in neuromuscular disease (NMD) research and treatment.
-
1 month ago | 
sjogrenssyndromenews.com | Margarida Maia |Teresa Carvalho |Andrea Lobo
About 2 in 3 women and men with Sjögren’s disease experience challenges in their sexual lives that go beyond physical symptoms, such as vaginal dryness or difficulty getting and keeping an erection, and these may include stress, social taboos, and poor body image, a study finds.
-
1 month ago | 
epidermolysisbullosanews.com | Marisa Wexler |Andrea Lobo |Teresa Carvalho |Hawken Miller
Castle Creek Biosciences has secured $75 million in financing to support a Phase 3 trial testing its gene therapy to promote wound healing in people with dystrophic epidermolysis bullosa (DEB). The royalty financing agreement for Castle Creek‘s treatment, D-Fi, was led by Ligand Pharmaceuticals, which made a $50 million investment. Ligand said the investors will get “a high single-digit royalty” on worldwide sales of the treatment if it is ultimately brought to market.
-
2 months ago | 
ionline.sapo.pt | Teresa Carvalho
Poeta, nas suas muitas declinações, Maria Teresa Horta era a imagem feminina da insubmissão e da fulguração criadora. Das escritoras da sua geração foi a que mais longe levou o desígnio e o programa de rasgar o caminho de uma literatura dita feminina. Sempre preferiu os caminhos do risco e do perigo à navegação prudente. O desenho fálico que muitos dos seus poemas exibem foi ele mesmo uma «haste de coragem».
-
Jan 4, 2025 | 
sol.sapo.pt | Teresa Carvalho
Fez versos para casar, deu espaço a uniões improváveis e serventia ao amor desamparado, defendeu o consórcio amoroso entre o doméstico e o metafísico. Epítetos teve muitos, entre os quais «Marquesa de Rambouillet» (Eduardo Pitta) e «Luiz Pacheco de saias», como lhe chamou Eduardo Prado Coelho.
-
Dec 31, 2024 | 
sol.sapo.pt | Diogo Pinto |José Cabrita Saraiva |Ricardo Norte |Teresa Carvalho
Poesia Quase TodaZbigniew HerbertED. Cavalo de FerroSe o conflito é a grande lógica que se inscreve no avesso destes dias, a nós, feitos de sangue e ilusão, cumpre-nos retirarmos alguma consequência de gestos esvaziados de sentido, à semelhança desse que «junta as mãos em concha como quem guarda uma memória/ sementes secas dos nomes dos mortos», com a confiança de que daí «outra floresta sobrevirá».
-
Nov 22, 2024 | 
pulmonaryhypertensionnews.com | Marisa Wexler |Margarida Maia |Teresa Carvalho |Steve Bryson
High levels of a small RNA molecule in the blood may be a marker of pulmonary arterial hypertension (PAH) in people with congenital heart diseases, a new study reveals. The study, “Expression and Diagnostic Value of miR-3591-5p in Patients with Congenital Heart Disease-Associated Pulmonary Arterial Hypertension,” was published in Lung. PAH is marked by high blood pressure in the vessels that carry blood through the lungs.
-
Nov 20, 2024 | 
cushingsdiseasenews.com | Andrea Lobo |Marisa Wexler |Teresa Carvalho |Steve Bryson
People with Cushing’s syndrome are at a high risk of glaucoma — an eye condition in which the optic nerve that connects the eye and brain becomes damaged, potentially leading to vision loss — according to a new study that found the risk for Cushing’s patients is 74% greater than that of the general population. Further, the clinical manifestation of glaucoma — the age at onset — occurred earlier among people with Cushing’s, regardless of whether or not they were in remission.
-
Nov 19, 2024 | 
sclerodermanews.com | Steve Bryson |Marisa Wexler |Teresa Carvalho |Joana Carvalho
Cells derived from people with systemic sclerosis (SSc) had widespread DNA mutations compared with healthy cells, which may explain the higher risk of cancer in this patient population, according to a study. Changes included mutational patterns found solely in the genomes of certain cancers, as well as changes in one or two DNA building blocks, insertions and deletions of DNA segments, and alterations in whole chromosomes.
-
Nov 13, 2024 | 
alsnewstoday.com | Andrea Lobo |Teresa Carvalho |Margarida Maia |Esteban Cerezo
Kadimastem, the developer of the experimental amyotrophic lateral sclerosis (ALS) therapy AstroRx, is merging with NLS Pharmaceutics to combine efforts to advance both companies’ drug portfolios. The combined company will focus on moving AstroRx and a diabetes drug being developed by Kadimastem through clinical trials. A Phase 2a study of AstroRx is planned in the U.S. after January 2025, after the agreement is finalized.
